Rama Gangula
Last active: 12/20/2016


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM (2007) Cancer Cell 12(6): 559-71
    › Primary publication · 18068632 (PubMed)
  2. Conditional activation of FGFR1 in the prostate epithelium induces angiogenesis with concomitant differential regulation of Ang-1 and Ang-2. Winter SF, Acevedo VD, Gangula RD, Freeman KW, Spencer DM, Greenberg NM (2007) Oncogene 26(34): 4897-907
    › Primary publication · 17297442 (PubMed)
  3. Versatile prostate cancer treatment with inducible caspase and interleukin-12. Nikitina EY, Desai SA, Zhao X, Song W, Luo AZ, Gangula RD, Slawin KM, Spencer DM (2005) Cancer Res 65(10): 4309-19
    › Primary publication · 15899823 (PubMed)
  4. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Freeman KW, Welm BE, Gangula RD, Rosen JM, Ittmann M, Greenberg NM, Spencer DM (2003) Cancer Res 63(23): 8256-63
    › Primary publication · 14678983 (PubMed)
  5. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, Rosen JM, Ittmann M, Greenberg NM, Spencer DM (2003) Cancer Res 63(19): 6237-43
    › Primary publication · 14559809 (PubMed)
  6. Cloning and functional characterization of a high-affinity Na(+)/dicarboxylate cotransporter from mouse brain. Pajor AM, Gangula R, Yao X (2001) Am J Physiol Cell Physiol 280(5): C1215-23
    › Primary publication · 11287335 (PubMed)